Findings reveal catalpol reduces bone loss in postmenopausal osteoporosis, impacting osteoblast apoptosis via SIRT1.
These findings support a SIRT1-centered mechanism whereby CAT engages SIRT1 in cells to restrain the P53-CASPASE-3 apoptotic program in osteoblasts and mitigate estrogen-deficiency bone loss in OVX mice.
No takes yet. Share an insight, caveat, or question.
Bian et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: